Last Posted: May 07, 2019
- Opportunities and challenges for transcriptome-wide association studies.
Wainberg Michael et al. Nature genetics 2019 51(4) 592-599 - The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease.
Kunovsky L et al. International journal of colorectal disease 2019 Feb 34(2) 347-351 - A blood-based prognostic biomarker in IBD.
Biasci Daniele et al. Gut 2019 Apr - Personalised medicine in inflammatory bowel diseases: a patient survey.
Choukour Myriam et al. Scandinavian journal of gastroenterology 2019 54(1) 135 - Biomedical risk assessment as an aid for smoking cessation.
Clair Carole et al. The Cochrane database of systematic reviews 2019 Mar 3CD004705 - Personalising medicine in inflammatory bowel disease-current and future perspectives.
Ashton James J et al. Translational pediatrics 2019 Jan 8(1) 56-69 - SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects.
Collij Valerie et al. PloS one 2019 (1) e0211328 - Microbial network disturbances in relapsing refractory Crohn's disease.
Yilmaz Bahtiyar et al. Nature medicine 2019 Jan - Clinical and Genetic Aspects of Behçet's Disease in Japan.
Kirino Yohei et al. Internal medicine (Tokyo, Japan) 2019 Jan - PRedicting Outcomes For Crohn's dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial.
Parkes Miles et al. BMJ open 2018 Dec 8(12) e026767
.png)
No hay comentarios:
Publicar un comentario